Replay available

IDEXX Laboratories, Inc. (IDXX) Q1 2026 Earnings Call

IDEXX Laboratories, Inc. (NASDAQ: IDXX) Q1 2026 earnings conference call, held 2026-05-05. Replay captured from the company's public earnings webcast.

Tue, May 5, 2026 at 8:30 AMendedReplay
IDEXX Laboratories, Inc. (IDXX) Q1 2026 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

John Ravis

Vice President, Investor Relations

Chris Schott

Analyst, JP Morgan

Daniel Grossleit

Analyst, Citi

Michael Ryskin

Analyst, Bank of America

Erin Wright

Analyst, Morgan Stanley

Daniel Clark

Analyst, Learing Partners

Andrew Emerson

Chief Financial Officer

John Block

Analyst, Stifel

Mike Erickson

Executive Vice President and incoming Chief Executive Officer

Jay Mazelski

President and Chief Executive Officer

Replay transcript excerpt

Good morning, and welcome to the IDEXX Laboratory's first quarter 2026 earnings conference call. As a reminder, today's conference is being recorded. Participating in the call this morning are Jay Mazelski, President and Chief Executive Officer, Mike Erickson, Executive Vice President and incoming Chief Executive Officer, Andrew Emerson, Chief Financial Officer, and John Ravis, Vice President, Investor Relations. IDEXX would like to preface the discussion today with a caution regarding forward-looking statements. Listeners are reminded that our discussion during the call will include forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those discussed today. Additional information regarding these risks and uncertainties is available under the forward-looking statements notice in our press release issued this morning, as well as in our periodic filings with the Securities and Exchange Commission, which can be obtained from the SEC or by visiting the investor relations section of our website, IDEX.com. During this call, we will be discussing certain financial measures not prepared in accordance with generally accepted accounting principles or GAAP. A reconciliation of these non-GAAP financial measures to the most directly comparable GAAP measures is provided in our earnings release, which may also be found by visiting the investor relations section of our website. In reviewing our first quarter 2026 results in 2026 financial outlook, please note all references to growth, organic growth, and comparable growth refer to growth compared to the equivalent prior year period, unless otherwise noted. To allow broad participation in the Q&A, we ask that each participant limit their questions to one, wit...

More from Idexx Laboratories, Inc.